Studies on the renal excretion of the acyl glucuronide, phenolic glucuronide and sulphate conjugates of diflunisal.
暂无分享,去创建一个
G. Herkes | M. Eadie | W. Hooper | R. Dickinson | A. R. King | G. McKinnon
[1] L. Benet,et al. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.
[2] R. Dickinson,et al. Studies on the reactivity of acyl glucuronides--II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. , 1991, Biochemical pharmacology.
[3] R. Dickinson,et al. Studies on the reactivity of acyl glucuronides--I. Phenolic glucuronidation of isomers of diflunisal acyl glucuronide in the rat. , 1991, Biochemical pharmacology.
[4] M. Ueno,et al. Sulphate conjugation enhances reversible binding of drug to human serum albumin , 1991, The Journal of pharmacy and pharmacology.
[5] S. Pond,et al. Diflunisal and its conjugates in patients with renal failure. , 1991, British journal of clinical pharmacology.
[6] J. Hansen-Møller,et al. The sulphate conjugate of diflunisal: its synthesis and systemic stability in the rat. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[7] R. Dickinson,et al. Contrasting systemic stabilities of the acyl and phenolic glucuronides of diflunisal in the rat. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[8] R. Herman,et al. The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man. , 1990, British journal of clinical pharmacology.
[9] L. Benet,et al. Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin. , 1990, Biochemical pharmacology.
[10] R. Dickinson,et al. Reactivity Considerations in the Analysis of Glucuronide and Sulfate Conjugates of Diflunisal , 1989, Therapeutic Drug Monitoring.
[11] L. Benet,et al. Probenecid‐induced changes in the clearance of carprofen enantiomers: A preliminary study , 1989, Clinical pharmacology and therapeutics.
[12] R. Dickinson,et al. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. , 1989, Research communications in chemical pathology and pharmacology.
[13] A. Munafo,et al. Disposition and irreversible plasma protein binding of tolmetin in humans , 1988, Clinical pharmacology and therapeutics.
[14] R. Herman,et al. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies. , 1988, British journal of clinical pharmacology.
[15] L. Benet,et al. Effect of probenecid on the formation and elimination of acyl glucuronides: Studies with zomepirac , 1985, Clinical pharmacology and therapeutics.
[16] Roger L. Williams,et al. Effects of probenecid on ketoprofen kinetics , 1982, Clinical pharmacology and therapeutics.
[17] P. Dayton,et al. Clinical Pharmacokinetics of Probenecid , 1981, Clinical pharmacokinetics.
[18] L. Prescott,et al. Failure of alkaline diuresis to enhance diflunisal elimination. , 1980, British journal of clinical pharmacology.
[19] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.